Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Characterization of the glycosylation occupancy and the active site in the follow-on protein therapeutic: TNK-tissue plasminogen activator.

Jiang H, Wu SL, Karger BL, Hancock WS.

Anal Chem. 2010 Jul 15;82(14):6154-62. doi: 10.1021/ac100956x.

PMID:
20552988
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Left ventricular mass index and coronary artery disease in hypertensive black males.

Robinson FC, Satterwhite K, Potter C, Craddock K, Beyoglu SA.

J Natl Med Assoc. 1993 Jun;85(6):452-6.

PMID:
8366535
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy.

Hogg PJ, Jackson CM.

Proc Natl Acad Sci U S A. 1989 May;86(10):3619-23.

PMID:
2726739
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Guidelines for the use of intravenous thrombolytic agents in acute myocardial infarction. Ontario Medical Association Consensus Group on Thrombolytic Therapy.

Naylor CD, Armstrong PW.

CMAJ. 1989 Jun 1;140(11):1289-99. Erratum in: Can Med Assoc J 1989 Jul 15;141(2):104.

PMID:
2497946
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

A pilot study of the efficacy and safety of bolus administration of alteplase in acute myocardial infarction.

Gemmill JD, Hogg KJ, MacIntyre PD, Booth N, Rae AP, Dunn FG, Hillis WS.

Br Heart J. 1991 Aug;66(2):134-8.

PMID:
1909151
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk